Status:
COMPLETED
Effect of Camel Milk With Probiotic on Type 2 Diabetes Mellitus
Lead Sponsor:
China Agricultural University
Collaborating Sponsors:
Beijing Chinese Medicine Hospital-Pinggu Hospital
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
35-68 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to investigate the effects of dietary supplement with Camel Milk containing Bifidobacterium animalis A6 on the plasma glucose and other related cytokines in patients with ...
Eligibility Criteria
Inclusion
- Age between 35\~68 years old
- Patients who diagnosed as type 2 diabetes
- Agree to take the products to be studied during the study period, and no longer take other fermented dairy products (live lactic acid bacteria drinks, cheese, yogurt, probiotic products, etc.) and antibiotic
- Agree to sign the informed consent form
Exclusion
- Taking antibiotics or antifungal drugs within 7 days before the study
- Have serious allergic reaction to skim milk powder or milk
- Researcher are not sure whether the subjects are willing or able to complete the study
- Subject had other serious diseases
Key Trial Info
Start Date :
June 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 9 2018
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT04296825
Start Date
June 1 2018
End Date
July 9 2018
Last Update
March 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Chinese Medicine Hospital Pinggu Hospital
Beijing, China